| ADTX | Aditxt Inc | 0.02 | -98.87% |
| LSB | LakeShore Biopharma Co Ltd | 0.03 | -98.47% |
| NTBL | Notable Labs Inc Ord | 0.03 | -97.98% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.04 | -97.87% |
| TNFA | TNF Pharmaceuticals Inc | 0.05 | -97.21% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 0.05 | -96.81% |
| AFMD | Affimed N.V. | 0.06 | -96.31% |
| EPIX | Essa Pharma Inc | 0.08 | -95.18% |
| ENLV | Enlivex Therapeutics Ltd | 0.10 | -94.24% |
| PBM | Psyence Biomedical Ltd | 0.12 | -93.24% |
| ONCO | Onconetix Inc | 0.12 | -93.24% |
| PPBT | Purple Biotech Ltd | 0.14 | -91.54% |
| ENTO | Entero Therapeutics, Inc. Common Stock | 0.15 | -91.01% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 0.16 | -90.77% |
| ONCT | Oncternal Therapeutics Inc | 0.17 | -89.98% |
| PPCB | Propanc Biopharma Inc | 0.18 | -89.12% |
| PMCB | PharmaCyte Biotech Inc | 0.21 | -87.53% |
| GLMD | Galmed Pharmaceuticals Ltd | 0.26 | -84.48% |
| APRE | Aprea Therapeutics Inc | 0.27 | -84.01% |
| NCNA | NuCana plc | 0.28 | -83.65% |
| CTXR | Citius Pharmaceuticals Inc | 0.31 | -81.89% |
| CMND | Clearmind Medicine Inc | 0.31 | -81.89% |
| AZTR | Azitra Inc | 0.32 | -81.36% |
| REVB | Revelation Biosciences Inc | 0.33 | -80.59% |
| GRI | GRI Bio Inc | 0.35 | -79.24% |
| APM | Aptorum Group Ltd - Class A | 0.36 | -78.89% |
| MGX | Metagenomi Inc | 0.37 | -78.12% |
| ELAB | PMGC Holdings Inc | 0.40 | -76.46% |
| ENGN | enGene Holdings Inc | 0.41 | -75.95% |
| TCRX | Tscan Therapeutics Inc | 0.42 | -75.44% |
| BRNS | Barinthus Biotherapeutics Plc. | 0.42 | -75.30% |
| VRAX | Virax Biolabs Group Ltd - Class A | 0.42 | -75.18% |
| KTTA | Pasithea Therapeutics Corp | 0.42 | -75.07% |
| OGEN | Oragenics Inc | 0.44 | -74.36% |
| SEER | Seer Inc - Class A | 0.44 | -74.24% |
| PLRX | Pliant Therapeutics Inc | 0.48 | -72.01% |
| LNAI | Lunai Bioworks Inc | 0.48 | -71.72% |
| BBLG | Bone Biologics Corp | 0.48 | -71.66% |
| GNPX | Genprex Inc | 0.49 | -71.36% |
| VTGN | VistaGen Therapeutics Inc | 0.49 | -71.30% |
| GLPG | Galapagos NV | 0.49 | -70.95% |
| TIL | Instil Bio Inc | 0.50 | -70.66% |
| APVO | Aptevo Therapeutics Inc | 0.51 | -70.07% |
| BOLT | Bolt Biotherapeutics Inc | 0.51 | -69.77% |
| IMA | Ikena Oncology Inc | 0.55 | -67.78% |
| XBIT | XBiotech Inc | 0.55 | -67.72% |
| SLRN | Acelyrin Inc | 0.56 | -67.00% |
| MBIO | Mustang Bio Inc | 0.56 | -66.95% |
| FBIO | Fortress Biotech Inc | 0.56 | -66.78% |
| CDT | CDT Equity Inc | 0.57 | -66.65% |
| ACET | Adicet Bio Inc | 0.58 | -66.01% |
| BCYC | Bicycle Therapeutics Plc | 0.59 | -65.42% |
| CDIO | Cardio Diagnostics Holdings Inc | 0.60 | -64.78% |
| LITS | Lite Strategy Inc | 0.61 | -64.25% |
| ACHL | Achilles Therapeutics Plc | 0.61 | -64.07% |
| GRCE | Acasti Pharma Inc | 0.61 | -63.89% |
| MURA | Mural Oncology plc | 0.64 | -62.31% |
| VOR | Vor Biopharma Inc | 0.66 | -61.48% |
| CLDI | Calidi Biotherapeutics Inc | 0.66 | -61.07% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.69 | -59.37% |
| AGIO | Agios Pharmaceuticals Inc | 0.69 | -59.25% |
| ORMP | Oramed Pharmaceuticals Inc | 0.69 | -59.19% |
| BIVI | BioVie Inc - Class A | 0.70 | -58.78% |
| DWTX | Virios Therapeutics Inc | 0.70 | -58.54% |
| HLVX | HilleVax Inc | 0.71 | -58.33% |
| PMVP | PMV Pharmaceuticals Inc | 0.72 | -57.54% |
| ACRV | Acrivon Therapeutics Inc | 0.73 | -56.78% |
| BLRX | Bioline Rx Ltd | 0.76 | -55.54% |
| ARTL | Artelo Biosciences Inc | 0.76 | -55.13% |
| INAB | IN8bio Inc | 0.77 | -54.49% |
| PEPG | PepGen Inc | 0.78 | -54.31% |
| KROS | Keros Therapeutics Inc | 0.78 | -54.31% |
| XLO | Xilio Therapeutics Inc | 0.79 | -53.37% |
| PHIO | Phio Pharmaceuticals Corp | 0.80 | -52.72% |
| LPCN | Lipocine Inc | 0.82 | -51.60% |
| NKTX | Nkarta Inc | 0.83 | -51.43% |
| GNTA | Genenta Science SpA | 0.83 | -51.13% |
| TOVX | Theriva Biologics Inc | 0.85 | -50.25% |
| BCTX | BriaCell Therapeutics Corp - New | 0.85 | -50.19% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 0.85 | -49.90% |
| DRMA | Dermata Therapeutics Inc | 0.85 | -49.84% |
| VIVS | VivoSim Labs Inc | 0.85 | -49.78% |
| ENSC | Ensysce Biosciences Inc | 0.85 | -49.72% |
| NXTC | Nextcure Inc | 0.86 | -49.66% |
| ENVB | Enveric Biosciences Inc | 0.86 | -49.25% |
| BGMS | Bio Green Med Solution Inc | 0.89 | -47.90% |
| IMRN | Immuron Ltd | 0.89 | -47.66% |
| THRD | Third Harmonic Bio Inc | 0.89 | -47.61% |
| KPRX | Kiora Pharmaceuticals Inc | 0.90 | -47.08% |
| HYPD | Eyenovia Inc | 0.91 | -46.37% |
| SAVA | Cassava Sciences Inc. | 0.92 | -45.78% |
| ATYR | Atyr Pharma Inc | 0.93 | -45.61% |
| IMMP | Immutep Ltd | 0.93 | -45.49% |
| VYNE | VYNE Therapeutics Inc | 0.93 | -45.43% |
| ADVM | Adverum Biotechnologies Inc | 0.93 | -45.31% |
| NBP | NovaBridge Biosciences. | 0.94 | -44.67% |
| MBRX | Moleculin Biotech Inc | 0.95 | -44.37% |
| RNA | Atrium Therapeutics Inc | 0.95 | -44.14% |
| JANX | Janux Therapeutics Inc | 0.95 | -43.84% |
| TRDA | Entrada Therapeutics Inc | 0.98 | -42.49% |
| CLGN | CollPlant Biotechnologies Ltd New | 0.98 | -42.14% |
| LENZ | LENZ Therapeutics Inc | 0.99 | -41.78% |
| NEUP | Neuphoria Therapeutics Inc | 0.99 | -41.67% |
| PRTC | PureTech Health plc American Depositary Shares | 1.00 | -40.90% |
| XBIO | Xenetic Biosciences Inc | 1.01 | -40.55% |
| CVAC | CureVac N.V. | 1.03 | -39.55% |
| AARD | Aardvark Therapeutics Inc | 1.03 | -39.37% |
| FDMT | 4D Molecular Therapeutics Inc | 1.04 | -39.08% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | 1.05 | -38.26% |
| VERU | Veru Inc | 1.07 | -36.79% |
| ALGS | Aligos Therapeutics Inc | 1.13 | -33.73% |
| RADX | Radiopharm Theranostics Ltd | 1.13 | -33.55% |
| QNRX | Quoin Pharmaceuticals Ltd | 1.13 | -33.37% |
| ARCT | Arcturus Therapeutics Holdings Inc | 1.14 | -33.14% |
| AKTX | Akari Therapeutics Plc | 1.14 | -32.89% |
| IBIO | iBio Inc | 1.17 | -31.26% |
| SRPT | Sarepta Therapeutics Inc | 1.17 | -31.20% |
| SPRC | SciSparc Ltd | 1.19 | -30.25% |
| INTS | Intensity Therapeutics Inc | 1.19 | -29.91% |
| SABS | SAB Biotherapeutics Inc | 1.21 | -29.08% |
| ACXP | Acurx Pharmaceuticals Inc | 1.21 | -28.67% |
| INVA | Innoviva Inc | 1.22 | -28.44% |
| CURX | Curanex Pharmaceuticals Inc | 1.22 | -28.32% |
| JAGX | Jaguar Health Inc | 1.23 | -27.65% |
| BDTX | Black Diamond Therapeutics Inc | 1.24 | -26.97% |
| SILO | SILO Pharma Inc | 1.25 | -26.32% |
| SNSE | Sensei Biotherapeutics Inc | 1.26 | -25.85% |
| CVM | Cel-Sci Corp | 1.29 | -24.08% |
| CANF | Can-Fite Biopharma Ltd | 1.32 | -22.50% |
| QNCX | Quince Therapeutics Inc | 1.33 | -21.85% |
| IMUX | Immunic Inc | 1.35 | -20.79% |
| FULC | Fulcrum Therapeutics Inc | 1.36 | -19.97% |
| VYGR | Voyager Therapeutics Inc | 1.37 | -19.61% |
| CMMB | Chemomab Therapeutics Ltd | 1.38 | -18.91% |
| VNDA | Vanda Pharmaceuticals Inc | 1.39 | -18.56% |
| RCKT | Rocket Pharmaceuticals Inc | 1.39 | -18.56% |
| ATOS | Atossa Therapeutics Inc | 1.39 | -18.44% |
| RIGL | Rigel Pharmaceuticals | 1.39 | -18.26% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 1.40 | -17.97% |
| CELZ | Creative Medical Technology Holdings Inc | 1.40 | -17.79% |
| IKT | Inhibikase Therapeutics Inc | 1.40 | -17.56% |
| ADXN | Addex Therapeutics Ltd | 1.42 | -16.38% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 1.43 | -16.09% |
| LYEL | Lyell Immunopharma Inc | 1.44 | -15.56% |
| PLRZ | Polyrizon Ltd | 1.47 | -13.50% |
| TARA | Protara Therapeutics Inc | 1.48 | -13.26% |
| ADIL | Adial Pharmaceuticals Inc | 1.48 | -13.21% |
| UPB | Upstream Bio Inc | 1.49 | -12.50% |
| ARVN | Arvinas Inc | 1.50 | -11.79% |
| OABI | OmniAb Inc | 1.50 | -11.74% |
| CLRB | Cellectar Biosciences Inc | 1.51 | -10.91% |
| CRMD | CorMedix Inc | 1.52 | -10.62% |
| LGVN | Longeveron Inc - Class A | 1.52 | -10.56% |
| RLYB | Rallybio Corp | 1.54 | -9.68% |
| MTNB | Matinas Biopharma Holdings Inc | 1.55 | -8.91% |
| SGMT | Sagimet Biosciences Inc - Class A | 1.55 | -8.56% |
| ZNTL | Zentalis Pharmaceuticals Inc | 1.56 | -8.32% |
| IPSC | Century Therapeutics Inc | 1.57 | -7.85% |
| IMRX | Immuneering Corp Class A | 1.58 | -6.80% |
| MREO | Mereo Biopharma Group Plc | 1.60 | -5.68% |
| PASG | Passage Bio Inc | 1.61 | -5.44% |
| KRRO | Korro Bio Inc | 1.61 | -5.03% |
| AVIR | Atea Pharmaceuticals Inc | 1.62 | -4.97% |
| PMN | ProMIS Neurosciences Inc | 1.62 | -4.80% |
| TNYA | Tenaya Therapeutics Inc | 1.64 | -3.74% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 1.65 | -3.11% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 1.65 | -2.76% |
| IVVD | Invivyd Inc | 1.65 | -2.74% |
| MNOV | Medicinova Inc | 1.66 | -2.68% |
| XNCR | Xencor Inc | 1.67 | -1.56% |
| ALXO | Alx Oncology Holdings Inc | 1.68 | -1.21% |
| PRTA | Prothena Corporation plc | 1.69 | -0.92% |
| MOLN | Molecular Partners AG | 1.72 | +1.32% |
| IMAB | I-Mab | 1.73 | +1.52% |
| CRIS | Curis Inc | 1.74 | +2.26% |
| LXEO | Lexeo Therapeutics Inc | 1.74 | +2.44% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1.76 | +3.55% |
| MTVA | MetaVia Inc | 1.76 | +3.73% |
| CCCC | C4 Therapeutics Inc | 1.76 | +3.79% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 1.77 | +4.32% |
| KLRS | Kalaris Therapeutics Inc | 1.80 | +6.14% |
| REPL | Replimune Group Inc | 1.81 | +6.32% |
| ERNA | Ernexa Therapeutics Inc | 1.81 | +6.67% |
| SVA | Sinovac Biotech Ltd | 1.82 | +6.79% |
| HOWL | Werewolf Therapeutics Inc | 1.82 | +6.96% |
| MRKR | Marker Therapeutics Inc | 1.82 | +7.32% |
| ZURA | Zura Bio Ltd - Class A | 1.84 | +8.08% |
| FATE | Fate Therapeutics Inc | 1.84 | +8.32% |
| ASBP | Aspire Biopharma Holdings Inc | 1.85 | +8.85% |
| ABCL | AbCellera Biologics Inc | 1.87 | +9.90% |
| GTBP | GT Biopharma Inc | 1.87 | +10.14% |
| NGNE | Neoleukin Therapeutics Inc | 1.88 | +10.49% |
| PULM | Pulmatrix Inc | 1.88 | +10.61% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | 1.90 | +11.85% |
| INMB | INmune Bio Inc | 1.91 | +12.32% |
| ATHE | Alterity Therapeutics Ltd | 1.91 | +12.37% |
| ALT | Altimmune Inc | 1.93 | +13.43% |
| SLDB | Solid Biosciences Inc | 1.93 | +13.55% |
| ANTX | AN2 Therapeutics Inc | 1.97 | +15.55% |
| GPCR | Structure Therapeutics Inc | 1.97 | +16.02% |
| VIR | Vir Biotechnology Inc | 1.98 | +16.55% |
| GRDX | Entero Therapeutics Inc | 2.00 | +17.43% |
| ICU | SeaStar Medical Holding Corp | 2.00 | +17.61% |
| HRMY | Harmony Biosciences Holdings Inc | 2.00 | +17.78% |
| ALZN | Alzamend Neuro Inc | 2.00 | +17.78% |
| CTNM | Contineum Therapeutics Inc - Class A | 2.02 | +18.61% |
| WHWK | Whitehawk Therapeutics Inc | 2.04 | +19.90% |
| CYCN | Cyclerion Therapeutics Inc | 2.05 | +20.37% |
| KAPA | Kairos Pharma Ltd | 2.05 | +20.72% |
| LBRX | LB Pharmaceuticals Inc | 2.08 | +22.61% |
| REGN | Regeneron Pharmaceuticals Inc | 2.09 | +23.14% |
| ABOS | Acumen Pharmaceuticals Inc | 2.10 | +23.31% |
| IVA | Inventiva | 2.10 | +23.67% |
| BRTX | BioRestorative Therapies Inc | 2.10 | +23.67% |
| ORIC | ORIC Pharmaceuticals Inc | 2.11 | +23.90% |
| ARMP | Armata Pharmaceuticals Inc | 2.11 | +24.08% |
| STRO | Sutro Biopharma Inc | 2.11 | +24.14% |
| EVAX | Evaxion Biotech A/S | 2.14 | +25.78% |
| TRAW | Traws Pharma Inc | 2.16 | +27.19% |
| SER | AgeX Therapeutics Inc | 2.17 | +27.90% |
| MDXG | Mimedx Group Inc | 2.22 | +30.72% |
| AVXL | Anavex Life Sciences Corporation | 2.23 | +30.84% |
| ABEO | Abeona Therapeutics Inc | 2.24 | +31.54% |
| TVRD | Cara Therapeutics Inc | 2.25 | +32.19% |
| CRBU | Caribou Biosciences Inc | 2.26 | +32.66% |
| NAUT | Nautilus Biotechnology Inc | 2.28 | +34.01% |
| DTIL | Precision Biosciences Inc | 2.29 | +34.60% |
| LRMR | Larimar Therapeutics Inc | 2.29 | +34.72% |
| FBLG | FibroBiologics Inc | 2.30 | +35.48% |
| COYA | Coya Therapeutics Inc | 2.31 | +36.07% |
| XFOR | X4 Pharmaceuticals Inc | 2.32 | +36.31% |
| OLMA | Olema Pharmaceuticals Inc | 2.32 | +36.31% |
| CMPX | Compass Therapeutics Inc | 2.32 | +36.60% |
| LEXX | Lexaria Bioscience Corp | 2.33 | +36.90% |
| ACOG | Alpha Cognition Inc | 2.35 | +37.95% |
| WVE | Wave Life Sciences Ltd | 2.38 | +40.07% |
| OVID | Ovid Therapeutics Inc | 2.39 | +40.60% |
| ALDX | Aldeyra Therapeutics Inc | 2.42 | +42.60% |
| HIND | ReShape Lifesciences Inc | 2.44 | +43.19% |
| PCVX | Vaxcyte Inc | 2.46 | +44.60% |
| PTN | Palatin Technologies Inc | 2.47 | +45.01% |
| SRZN | Surrozen Inc | 2.50 | +47.30% |
| ARTV | Artiva Biotherapeutics Inc | 2.54 | +49.24% |
| MRNA | Moderna Inc | 2.55 | +49.95% |
| TECX | AvroBio Inc | 2.55 | +50.13% |
| PLX | Protalix BioTherapeutics Inc | 2.56 | +50.83% |
| CTMX | CytomX Therapeutics Inc | 2.59 | +52.42% |
| CGEM | Cullinan Oncology Inc | 2.60 | +53.18% |
| GDTC | CytoMed Therapeutics Ltd | 2.61 | +53.42% |
| NCEL | NLS Pharmaceutics Ltd | 2.62 | +53.77% |
| PTHS | Channel Therapeutics Corporation | 2.62 | +54.13% |
| NRSN | NeuroSense Therapeutics Ltd | 2.64 | +55.42% |
| KYTX | Kyverna Therapeutics Inc | 2.65 | +55.71% |
| GOSS | Gossamer Bio Inc | 2.66 | +56.65% |
| NERV | Minerva Neurosciences Inc | 2.68 | +57.48% |
| BCAB | BioAtla Inc | 2.68 | +57.65% |
| ALLO | Allogene Therapeutics Inc | 2.69 | +57.95% |
| RZLT | Rezolute Inc | 2.69 | +58.24% |
| FTRE | FORTE SOFTWARE INC | 2.70 | +58.54% |
| IOVA | Iovance Biotherapeutics Inc | 2.70 | +58.77% |
| CRVO | CervoMed Inc | 2.72 | +60.01% |
| AIM | AIM ImmunoTech Inc. | 2.73 | +60.24% |
| ASMB | Assembly Biosciences Inc | 2.73 | +60.77% |
| CGEN | Compugen Ltd | 2.74 | +61.30% |
| TENX | Tenax Therapeutics Inc | 2.75 | +61.59% |
| IDYA | Ideaya Biosciences Inc | 2.75 | +61.59% |
| LSTA | Lisata Therapeutics Inc | 2.75 | +62.01% |
| EVMN | Evommune Inc | 2.76 | +62.24% |
| BCAX | Bicara Therapeutics Inc | 2.78 | +63.48% |
| MCRB | Seres Therapeutics Inc | 2.79 | +63.95% |
| PCSA | Processa Pharmaceuticals Inc | 2.81 | +65.12% |
| PALI | Palisade Bio Inc | 2.82 | +65.71% |
| HCWB | HCW Biologics Inc | 2.84 | +67.00% |
| CRSP | CRISPR Therapeutics AG | 2.85 | +67.30% |
| GMAB | Genmab | 2.85 | +67.36% |
| PBYI | Puma Biotechnology Inc | 2.87 | +68.53% |
| TBPH | Theravance Biopharma Inc | 2.88 | +69.18% |
| ANRO | Alto Neuroscience Inc | 2.89 | +70.18% |
| BEAM | Beam Therapeutics Inc | 2.90 | +70.30% |
| NRXP | NRX Pharmaceuticals Inc | 2.90 | +70.77% |
| ACAD | Acadia Pharmaceuticals Inc | 2.92 | +71.53% |
| CRNX | Crinetics Pharmaceuticals Inc | 2.93 | +72.06% |
| CYBN | Cybin Inc | 2.94 | +72.65% |
| IMTX | Immatics N.V | 2.95 | +73.53% |
| MLEC | Moolec Science SA | 3.00 | +76.14% |
| NTLA | Intellia Therapeutics Inc | 3.02 | +77.82% |
| MAIA | MAIA Biotechnology Inc | 3.04 | +79.00% |
| XRTX | XORTX Therapeutics Inc | 3.05 | +79.12% |
| AURA | Aura Biosciences Inc | 3.06 | +80.06% |
| CING | Cingulate Inc | 3.07 | +80.41% |
| EQ | Equillium Inc | 3.07 | +80.65% |
| CBUS | Cibus Global Ltd. Class A | 3.08 | +80.88% |
| DSGN | Design Therapeutics Inc | 3.08 | +81.00% |
| GLUE | Monte Rosa Therapeutics Inc | 3.14 | +84.47% |
| ICCC | Immucell Corp | 3.14 | +84.76% |
| ZLAB | Zai Lab Ltd | 3.17 | +86.53% |
| SPRO | Spero Therapeutics Inc | 3.20 | +88.17% |
| MNPR | Monopar Therapeutics Inc | 3.21 | +88.64% |
| OCUL | Ocular Therapeutix Inc | 3.21 | +89.06% |
| CHRS | Coherus Biosciences Inc | 3.26 | +91.52% |
| CBIO | Crescent Biopharma Inc | 3.28 | +92.94% |
| JAZZ | Jazz Pharmaceuticals plc | 3.29 | +93.41% |
| SKYE | Skye Bioscience Inc | 3.29 | +93.76% |
| ABVC | ABVC BioPharma Inc | 3.31 | +94.47% |
| ZVRA | Zevra Therapeutics Inc | 3.33 | +95.76% |
| PSTV | Plus Therapeutics Inc | 3.35 | +96.93% |
| ENTA | Enanta Pharmaceuticals Inc | 3.37 | +98.23% |
| MPLT | MapLight Therapeutics Inc | 3.38 | +98.58% |
| ADCT | Adc Therapeutics SA | 3.42 | +101.35% |
| INCY | Incyte Corp | 3.46 | +103.34% |
| MBX | MBX Biosciences Inc | 3.46 | +103.76% |
| JBIO | Jade Biosciences Inc | 3.46 | +103.76% |
| DYN | Dyne Therapeutics Inc | 3.47 | +103.87% |
| RPRX | Royalty Pharma plc - Class A | 3.47 | +104.23% |
| RLMD | Relmada Therapeutics Inc | 3.48 | +104.87% |
| ZBIO | Zenas Biopharma Inc | 3.49 | +105.17% |
| CNTB | Connect Biopharma Holdings Ltd | 3.52 | +106.76% |
| ABUS | Arbutus Biopharma Corp | 3.52 | +106.93% |
| AUPH | Aurinia Pharmaceuticals Inc | 3.52 | +107.05% |
| GERN | Geron Corp | 3.53 | +107.46% |
| CRDF | Cardiff Oncology Inc | 3.55 | +108.75% |
| CGTX | Cognition Therapeutics Inc | 3.56 | +109.40% |
| PHAR | Pharming Group N.V. | 3.59 | +110.93% |
| SEPN | Septerna Inc | 3.59 | +111.05% |
| DNLI | Denali Therapeutics Inc | 3.59 | +111.05% |
| PYXS | Pyxis Oncology Inc | 3.61 | +112.11% |
| TECH | Bio-Techne Corp | 3.61 | +112.34% |
| MESO | Mesoblast Ltd | 3.65 | +114.63% |
| NAGE | Niagen Bioscience Inc | 3.73 | +119.57% |
| IMCR | Immunocore Holdings plc | 3.75 | +120.34% |
| COCP | Cocrystal Pharma Inc | 3.75 | +120.63% |
| RANI | Rani Therapeutics Holdings Inc Class A | 3.77 | +121.40% |
| GNFT | GENFIT S.A. American Depositary Shares | 3.77 | +121.56% |
| AVTX | Avalo Therapeutics Inc | 3.78 | +122.34% |
| PRQR | ProQR Therapeutics N.V | 3.79 | +122.63% |
| CPRX | Catalyst Pharmaceuticals Inc | 3.79 | +122.63% |
| ALLR | Allarity Therapeutics Inc | 3.79 | +123.10% |
| NKTR | Nektar Therapeutics | 3.80 | +123.69% |
| NRIX | Nurix Therapeutics Inc | 3.82 | +124.57% |
| VRDN | Viridian Therapeutics Inc | 3.82 | +124.69% |
| SPRB | Spruce Biosciences Inc | 3.85 | +126.69% |
| IRON | Disc Medicine Inc | 3.86 | +127.04% |
| XENE | Xenon Pharmaceuticals Inc | 3.90 | +129.16% |
| DRUG | Bright Minds Biosciences Inc | 3.92 | +130.34% |
| RNXT | RenovoRx Inc | 3.95 | +132.22% |
| RAPP | Rapport Therapeutics Inc | 4.01 | +135.63% |
| KALA | Kala Bio Inc | 4.03 | +136.75% |
| QTTB | Q32 Bio Inc | 4.05 | +138.33% |
| MLYS | Mineralys Therapeutics Inc | 4.08 | +139.74% |
| RNAZ | TransCode Therapeutics Inc | 4.10 | +140.92% |
| CUE | Cue Biopharma Inc | 4.10 | +141.10% |
| DNTH | Dianthus Therapeutics Inc | 4.13 | +142.86% |
| ESLA | Estrella Immunopharma Inc | 4.13 | +143.04% |
| SNGX | Soligenix Inc | 4.15 | +144.21% |
| CLYM | Eliem Therapeutics Inc | 4.24 | +149.21% |
| KZIA | Kazia Therapeutics Ltd | 4.25 | +150.03% |
| MAZE | Maze Therapeutics Inc | 4.29 | +152.03% |
| EPRX | Eupraxia Pharmaceuticals Inc | 4.29 | +152.09% |
| CADL | Candel Therapeutics Inc | 4.29 | +152.09% |
| ANNX | Annexon Inc | 4.30 | +152.74% |
| IFRX | InflaRx N.V. | 4.30 | +153.09% |
| VTVT | vTv Therapeutics Inc - Class A | 4.32 | +154.29% |
| IMNM | Immunome Inc | 4.33 | +154.86% |
| AVBP | ArriVent BioPharma Inc | 4.35 | +155.56% |
| KYMR | Kymera Therapeutics Inc | 4.35 | +155.92% |
| NNVC | NanoViricides Inc | 4.36 | +156.09% |
| GRCL | Gracell Biotechnologies Inc | 4.39 | +158.21% |
| ACRS | Aclaris Therapeutics Inc | 4.45 | +161.85% |
| YMAB | Y-Mabs Therapeutics Inc | 4.46 | +162.25% |
| ETNB | 89bio Inc | 4.49 | +164.07% |
| CRVS | Corvus Pharmaceuticals Inc | 4.52 | +165.56% |
| VSTM | Verastem Inc | 4.58 | +169.50% |
| AUTL | Autolus Therapeutics plc | 4.60 | +170.38% |
| XOMA | XOMA Corp | 4.64 | +172.79% |
| APGE | Apogee Therapeutics Inc | 4.67 | +174.73% |
| SLGL | Sol-Gel Technologies Ltd | 4.67 | +174.85% |
| IGC | IGC Pharma Inc | 4.74 | +178.56% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 4.74 | +178.61% |
| ROIV | Roivant Sciences Ltd | 4.75 | +179.32% |
| TRML | Tourmaline Bio Inc | 4.77 | +180.35% |
| RLAY | Relay Therapeutics Inc | 4.77 | +180.38% |
| LXRX | Lexicon Pharmaceuticals Inc | 4.77 | +180.73% |
| ALMS | Alumis Inc | 4.81 | +182.97% |
| ADMA | Adma Biologics Inc | 4.83 | +184.20% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | 4.83 | +184.32% |
| STTK | Shattuck Labs Inc | 4.84 | +184.44% |
| MDWD | MediWound Ltd | 4.86 | +185.96% |
| NMRA | Neumora Therapeutics Inc | 4.90 | +188.26% |
| VCEL | Vericel Corp | 4.91 | +188.73% |
| EYPT | EyePoint Pharmaceuticals Inc | 4.94 | +190.49% |
| UNCY | Unicycive Therapeutics Inc | 4.97 | +192.32% |
| MIST | Milestone Pharmaceuticals Inc | 4.97 | +192.43% |
| STOK | Stoke Therapeutics Inc | 4.98 | +192.96% |
| TYRA | Tyra Biosciences Inc | 5.01 | +194.61% |
| CNTX | Context Therapeutics Inc | 5.03 | +195.78% |
| CGON | Cg Oncology Inc | 5.03 | +195.78% |
| VERA | Vera Therapeutics Inc - Class A | 5.10 | +199.90% |
| IMNN | Imunon Inc | 5.16 | +203.43% |
| NUVB | Nuvation Bio Inc - Class A | 5.18 | +204.61% |
| PRLD | Prelude Therapeutics Inc | 5.22 | +206.96% |
| DBVT | DBV Technologies | 5.28 | +210.49% |
| BMEA | Biomea Fusion Inc | 5.33 | +213.43% |
| BYSI | BeyondSpring Inc | 5.38 | +216.37% |
| CLDX | Celldex Therapeutics Inc | 5.40 | +217.54% |
| LEGN | Legend Biotech Corp | 5.42 | +218.72% |
| FBRX | Forte Biosciences Inc | 5.44 | +219.89% |
| ELVN | Enliven Therapeutics Inc | 5.46 | +221.07% |
| CDXS | Codexis Inc | 5.47 | +221.66% |
| ABSI | Absci Corp | 5.50 | +223.42% |
| MLTX | MoonLake Immunotherapeutics - Class A | 5.56 | +226.95% |
| ENTX | Entera Bio Ltd | 5.62 | +230.48% |
| GYRE | Gyre Therapeutics Inc | 5.65 | +232.24% |
| KLTO | Klotho Neurosciences Inc Com | 5.71 | +235.77% |
| VRTX | Vertex Pharmaceuticals Inc | 5.73 | +236.95% |
| OBIO | Orchestra BioMed Holdings Inc | 5.77 | +239.30% |
| TCRT | Alaunos Therapeutics Inc | 5.80 | +241.06% |
| GHRS | GH Research PLC | 5.83 | +242.83% |
| VANI | Vivani Medical Inc | 5.83 | +242.83% |
| ANIX | Anixa Biosciences Inc | 5.89 | +246.36% |
| CABA | Cabaletta Bio Inc | 5.95 | +249.88% |
| GUTS | Fractyl Health Inc | 5.99 | +252.24% |
| GNLX | Genelux Corp | 6.00 | +252.82% |
| SVRA | Savara Inc | 6.06 | +256.35% |
| RCUS | Arcus Biosciences Inc | 6.08 | +257.53% |
| CLLS | Cellectis | 6.10 | +258.71% |
| CAPR | Capricor Therapeutics Inc | 6.10 | +258.71% |
| GANX | Gain Therapeutics Inc | 6.15 | +261.65% |
| LCTX | Lineage Cell Therapeutics Inc | 6.15 | +261.65% |
| VRCA | Verrica Pharmaceuticals Inc | 6.16 | +262.23% |
| EVGN | Evogene Ltd | 6.18 | +263.41% |
| NTRB | Nutriband Inc | 6.20 | +264.59% |
| NAMS | NewAmsterdam Pharma Company NV | 6.23 | +266.35% |
| CMRX | Chimerix Inc | 6.30 | +270.20% |
| ONC | BeiGene Ltd | 6.33 | +272.23% |
| EXEL | Exelixis Inc | 6.49 | +281.64% |
| HURA | TuHURA Biosciences Inc | 6.56 | +285.75% |
| SLN | Silence Therapeutics Plc | 6.57 | +286.34% |
| ELDN | Eledon Pharmaceuticals Inc | 6.67 | +292.22% |
| VALN | Valneva SE | 6.69 | +293.40% |
| SION | Sionna Therapeutics Inc | 6.71 | +294.58% |
| DMAC | DiaMedica Therapeutics Inc | 6.86 | +303.40% |
| PRAX | Praxis Precision Medicines Inc | 6.96 | +309.28% |
| ARGX | Argen X SE | 6.97 | +309.86% |
| CALC | CalciMedica Inc | 6.98 | +310.45% |
| SLXN | Silexion Therapeutics Corp | 7.07 | +315.74% |
| KRYS | Krystal Biotech Inc | 7.08 | +316.33% |
| PVLA | Palvella Therapeutics Inc | 7.14 | +319.86% |
| OCS | Oculis Holding AG | 7.15 | +320.45% |
| NUVL | Nuvalent Inc - Class A | 7.23 | +325.15% |
| EWTX | Edgewise Therapeutics Inc | 7.26 | +326.92% |
| SANA | Sana Biotechnology Inc | 7.30 | +329.27% |
| ORKA | ARCA biopharma Inc | 7.30 | +329.27% |
| VKTX | Viking Therapeutics Inc | 7.32 | +330.45% |
| TARS | Tarsus Pharmaceuticals Inc | 7.34 | +331.62% |
| ADAG | Adagene Inc | 7.36 | +332.80% |
| TELO | Telomir Pharmaceuticals Inc | 7.38 | +333.97% |
| TNGX | Tango Therapeutics Inc | 7.39 | +334.56% |
| ACIU | AC Immune SA | 7.43 | +336.91% |
| IMMX | Immix Biopharma Inc | 7.46 | +338.68% |
| BLTE | Belite Bio Inc | 7.46 | +338.68% |
| JSPR | Jasper Therapeutics Inc | 7.48 | +339.85% |
| CAMP | CAMP4 Therapeutics Corp | 7.56 | +344.56% |
| PHVS | Pharvaris NV | 7.59 | +346.32% |
| APLT | Applied Therapeutics Inc | 7.72 | +353.97% |
| HYFT | MindWalk Holdings Corp | 7.77 | +356.91% |
| TLX | Telix Pharmaceuticals Ltd | 7.78 | +357.50% |
| CAI | Caris Life Sciences Inc - Class A | 7.94 | +366.90% |
| PRME | Prime Medicine Inc | 7.99 | +369.84% |
| ACHV | Achieve Life Sciences Inc | 7.99 | +369.84% |
| TSHA | Taysha Gene Therapies Inc | 8.00 | +370.43% |
| IMVT | Immunovant Inc | 8.07 | +374.55% |
| APLM | Apollomics Inc - Class A | 8.15 | +379.25% |
| ATAI | ATAI Life Sciences N.V. | 8.17 | +380.43% |
| KURA | Kura Oncology Inc | 8.42 | +395.13% |
| OMER | Omeros Corporation | 8.44 | +396.31% |
| CVKD | Cadrenal Therapeutics Inc | 8.56 | +403.36% |
| FENC | Fennec Pharmaceuticals Inc | 9.19 | +440.41% |
| AAPG | Ascentage Pharma Group International | 9.51 | +459.23% |
| ERAS | Erasca Inc | 9.64 | +466.87% |
| XCUR | Exicure Inc | 9.72 | +471.58% |
| CELU | Celularity Inc - Class A | 9.89 | +481.57% |
| LIXT | Lixte Biotechnology Holdings Inc | 10.01 | +488.63% |
| PTGX | Protagonist Therapeutics Inc | 10.02 | +489.22% |
| ARDX | Ardelyx Inc | 10.23 | +501.57% |
| TGTX | TG Therapeutics Inc | 10.29 | +505.09% |
| PYPD | Polypid Ltd | 10.44 | +513.91% |
| QURE | uniQure N.V. | 10.62 | +524.50% |
| COGT | Cogent Biosciences Inc | 11.13 | +554.49% |
| ZYME | Zymeworks BC Inc | 11.15 | +555.67% |
| CORT | Corcept Therapeutics Inc | 11.21 | +559.19% |
| INKT | MiNK Therapeutics Inc | 11.33 | +566.25% |
| BHVN | Biohaven Ltd | 11.91 | +600.36% |
| TRVI | Trevi Therapeutics Inc | 11.92 | +600.94% |
| KPTI | Karyopharm Therapeutics Inc | 12.05 | +608.59% |
| SYRE | Spyre Therapeutics Inc | 12.16 | +615.06% |
| SNTI | Senti Biosciences Inc | 12.20 | +617.41% |
| BCDA | BioCardia Inc | 12.35 | +626.23% |
| MGNX | Macrogenics Inc | 12.52 | +636.23% |
| CNTA | Centessa Pharmaceuticals plc | 12.64 | +643.28% |
| ACTU | Actuate Therapeutics Inc | 12.77 | +650.93% |
| LTRN | Lantern Pharma Inc | 13.18 | +675.04% |
| DRTS | Alpha Tau Medical Ltd | 13.19 | +675.63% |
| OSTX | OS Therapies Inc | 13.65 | +702.68% |
| OKYO | OKYO Pharma Ltd - New | 14.11 | +729.73% |
| GOVX | Geovax Labs Inc | 14.14 | +731.49% |
| ARQT | Arcutis Biotherapeutics Inc | 14.14 | +731.49% |
| LPTX | Leap Therapeutics Inc | 14.83 | +771.81% |
| SPRY | ARS Pharmaceuticals Inc | 15.22 | +795.00% |
| PDSB | PDS Biotechnology Corporation | 15.27 | +797.94% |
| NRXS | Neuraxis Inc | 15.72 | +824.40% |
| ATNM | Actinium Pharmaceuticals Inc | 15.80 | +829.10% |
| SLS | SELLAS Life Sciences Group Inc | 15.90 | +834.99% |
| ATRA | Atara Biotherapeutics Inc | 16.14 | +849.10% |
| RGNX | Regenxbio Inc | 16.41 | +864.98% |
| INO | Inovio Pharmaceuticals Inc | 17.76 | +944.36% |
| ARWR | Arrowhead Pharmaceuticals Inc | 18.12 | +965.53% |
| CSBR | Champions Oncology Inc | 18.81 | +1006.11% |
| NVCT | Nuvectis Pharma Inc | 19.00 | +1017.28% |
| URGN | UroGen Pharma Ltd | 19.27 | +1033.15% |
| IPHA | Innate Pharma | 20.10 | +1081.96% |
| KOD | Kodiak Sciences Inc | 20.49 | +1104.90% |
| DYAI | Dyadic International Inc DE | 21.01 | +1135.47% |
| ABVX | Abivax | 21.18 | +1145.47% |
| HRTX | Heron Therapeutics Inc | 21.29 | +1151.94% |
| SRRK | Scholar Rock Holding Corp | 21.42 | +1159.58% |
| MTSR | Metsera Inc | 21.96 | +1191.33% |
| TLSA | Tiziana Life Sciences Ltd | 22.09 | +1198.98% |
| RVMD | Revolution Medicines Inc | 22.33 | +1213.10% |
| MDGL | Madrigal Pharmaceuticals Inc | 22.39 | +1216.62% |
| ANVS | Annovis Bio Inc | 22.61 | +1229.56% |
| ALEC | Alector Inc | 23.10 | +1258.37% |
| IRD | Ocuphire Pharma Inc | 23.82 | +1300.71% |
| HUMA | Humacyte Inc | 24.64 | +1348.93% |
| SMMT | Summit Therapeutics Inc | 24.68 | +1351.29% |
| MIRM | Mirum Pharmaceuticals Inc | 25.05 | +1373.04% |
| PHAT | Phathom Pharmaceuticals Inc | 25.37 | +1391.86% |
| ASND | Ascendis Pharma A/S | 25.62 | +1406.56% |
| TTRX | Turn Therapeutics Inc | 25.69 | +1410.68% |
| IONS | Ionis Pharmaceuticals Inc | 25.72 | +1412.44% |
| PHGE | BiomX Inc | 26.81 | +1476.54% |
| RNTX | Rein Therapeutics Inc | 28.17 | +1556.51% |
| TPST | Tempest Therapeutics Inc | 31.25 | +1737.63% |
| RNAC | Cartesian Therapeutics Inc | 31.26 | +1738.22% |
| INSM | Insmed Inc | 33.49 | +1869.35% |
| EDSA | Edesa Biotech Inc | 35.33 | +1977.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 36.70 | +2058.11% |
| HALO | Halozyme Therapeutics Inc | 37.08 | +2080.46% |
| OTLK | Outlook Therapeutics Inc | 38.42 | +2159.25% |
| ANL | Adlai Nortye Ltd | 38.65 | +2172.93% |
| NVAX | Novavax Inc | 41.23 | +2324.49% |
| SNDX | Syndax Pharmaceuticals Inc | 41.75 | +2355.07% |
| TVTX | Travere Therapeutics Inc | 44.99 | +2545.60% |
| DARE | Dare Bioscience Inc | 47.97 | +2720.83% |
| KALV | KalVista Pharmaceuticals Inc | 49.03 | +2783.16% |
| RYTM | Rhythm Pharmaceuticals Inc | 51.00 | +2899.01% |
| EXOZ | Invizyne Technologies Inc | 54.63 | +3112.47% |
| CYTK | Cytokinetics Inc | 60.31 | +3446.48% |
| NBTX | Nanobiotix | 65.02 | +3723.44% |
| YDES | YD Bio Ltd | 66.53 | +3812.24% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 73.80 | +4239.74% |
| PGEN | Precigen Inc | 76.46 | +4396.16% |
| OCGN | Ocugen Inc | 80.18 | +4614.91% |
| PROK | ProKidney Corp - Class A | 100.75 | +5824.40% |
| CNSP | Cns Pharmaceuticals Inc | 106.55 | +6165.58% |
| CELC | Celcuity Inc | 122.06 | +7077.63% |
| EDIT | Editas Medicine Inc | 123.59 | +7167.60% |
| BBIO | BridgeBio Pharma Inc | 123.68 | +7172.89% |
| INDP | Indaptus Therapeutics Inc | 131.59 | +7638.03% |
| ANAB | AnaptysBio Inc | 131.64 | +7640.97% |
| ELTX | Elicio Therapeutics Inc | 132.74 | +7705.66% |
| GLSI | Greenwich LifeSciences Inc | 183.82 | +10709.37% |
| MNKD | Mannkind Corp | 187.85 | +10946.35% |
| GALT | Galectin Therapeutics Inc | 207.70 | +12113.61% |
| INBX | Inhibrx Biosciences Inc | 212.28 | +12382.93% |
| AGEN | Agenus Inc | 218.61 | +12755.16% |
| AXSM | Axsome Therapeutics Inc | 221.08 | +12900.41% |
| JUNS | Jupiter Neurosciences Inc | 227.66 | +13287.34% |
| MGTX | MeiraGTx Holdings plc | 228.30 | +13324.98% |
| RARE | Ultragenyx Pharmaceutical Inc | 247.70 | +14465.78% |
| VRNA | Verona Pharma Plc | 279.39 | +16329.43% |
| PLUR | Pluri Inc | 306.56 | +17926.98% |
| ONCY | Oncolytics Biotech Inc | 1055.04 | +61940.68% |
| PTCT | PTC Therapeutics Inc | 1743.27 | +102411.42% |
| FHTX | Foghorn Therapeutics Inc | 2005.35 | +117822.80% |